| 指标 | 组别 | 治疗前 | 治疗后 | 治疗前组间比较 | 治疗前后组内比较 | 治疗后组间比较 | |||
| 检验值 | P值 | 检验值 | P值 | 检验值 | P值 | ||||
| FEV1 (L) | 参照组 | 1.25 ± 0.35 | 2.58 ± 0.42 | t = 0.156 | 0.876 > 0.05 | t = 19.309 | 0.000 < 0.01 | t = 9.097 | 0.000 < 0.01 |
| 治疗组 | 1.24 ± 0.37 | 3.41 ± 0.59 | t = 24.732 | 0.000 < 0.01 | |||||
| PEF (L/sec) | 参照组 | 4.32 ± 0.78 | 5.64 ± 0.46 | t = 0.076 | 0.939 > 0.05 | t = 11.570 | 0.000 < 0.01 | t = 34.135 | 0.000 < 0.01 |
| 治疗组 | 4.33 ± 0.69 | 8.29 ± 0.41 | t = 39.161 | 0.000 < 0.01 | |||||
| FEV1/FEC(%) | 参照组 | 53.68 ± 5.32 | 61.38 ± 5.62 | t = 0.062 | 0.950 > 0.05 | t = 7.898 | 0.000 < 0.01 | t = 11.698 | 0.000 < 0.01 |
| 治疗组 | 53.62 ± 5.48 | 73.24 ± 5.76 | t = 19.588 | 0.000 < 0.01 | |||||
| PaCO2 (mmHg) | 参照组 | 50.18 ± 4.82 | 45.55 ± 4.49 | t = 0.052 | 0.958 > 0.05 | t = 5.579 | 0.000 < 0.01 | t = 6.456 | 0.000 < 0.01 |
| 治疗组 | 50.13 ± 5.87 | 40.21 ± 4.79 | t = 10.393 | 0.000 < 0.01 | |||||
| PaO2 (mmHg) | 参照组 | 58.75 ± 6.25 | 67.23 ± 5.77 | t = 0.009 | 0.993 > 0.05 | t = 7.913 | 0.000 < 0.01 | t = 9.609 | 0.000 < 0.01 |
| 治疗组 | 58.76 ± 6.14 | 78.11 ± 6.89 | t = 16.642 | 0.000 < 0.01 | |||||
| SaO2 (%) | 参照组 | 88.24 ± 3.76 | 93.54 ± 2.46 | t = 0.031 | 0.975 > 0.05 | t = 9.362 | 0.000 < 0.01 | t = 15.228 | 0.000 < 0.01 |
| 治疗组 | 88.26 ± 3.44 | 98.75 ± 1.15 | t = 22.955 | 0.000 < 0.01 | |||||